当前位置:首页 - 行情中心 - 亚虹医药-U(688176) - 财务分析 - 现金流量表

亚虹医药-U

(688176)

  

流通市值:77.07亿  总市值:77.07亿
流通股本:5.72亿   总股本:5.72亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金124,361,610.4273,137,012.47266,180,134.7207,293,835.96
  收到的税费返还378,553.3847,772.55430,651.25617,294.54
  收到其他与经营活动有关的现金4,085,346.091,393,157.2613,923,143.568,445,392.14
  经营活动现金流入小计128,825,509.8974,577,942.28280,533,929.51216,356,522.64
  购买商品、接受劳务支付的现金51,063,181.1915,568,772.3866,770,172.1450,033,446.07
  支付给职工以及为职工支付的现金158,400,747.8880,650,973.57254,646,044.84176,250,462.21
  支付的各项税费5,082,592.634,985,759.5922,627,477.1218,592,474.51
  支付其他与经营活动有关的现金215,156,494.697,876,903.75348,283,910.21273,279,040.97
  经营活动现金流出小计429,703,016.3199,082,409.29692,327,604.31518,155,423.76
  经营活动产生的现金流量净额-300,877,506.41-124,504,467.01-411,793,674.8-301,798,901.12
二、投资活动产生的现金流量:
  收回投资收到的现金1,308,057,995.43480,914,853.111,688,981,498.634,556,531,835.72
  处置固定资产、无形资产和其他长期资产收回的现金净额16,466.7810,901.2814,781.2119,144.05
  收到的其他与投资活动有关的现金--1,868,8021,868,984
  投资活动现金流入小计1,308,074,462.21480,925,754.391,690,865,081.844,558,419,963.77
  购建固定资产、无形资产和其他长期资产支付的现金50,075,030.713,726,247.3419,124,958.3912,766,519.15
  投资支付的现金1,230,000,000445,000,0001,634,120,0004,605,947,111.11
  投资活动现金流出小计1,280,075,030.71448,726,247.341,653,244,958.394,618,713,630.26
  投资活动产生的现金流量净额27,999,431.532,199,507.0537,620,123.45-60,293,666.49
三、筹资活动产生的现金流量:
  吸收投资收到的现金6,941,482.03-8,073,379.498,073,379.49
  取得借款收到的现金218,200,000106,790,000288,046,052.35231,285,966.9
  收到其他与筹资活动有关的现金37,807,332.96---
  筹资活动现金流入小计262,948,814.99106,790,000296,119,431.84239,359,346.39
  偿还债务支付的现金202,195,052.3588,096,027.666,200,00036,500,000
  分配股利、利润或偿付利息支付的现金3,354,570.21,622,853.714,080,668.477,075,691.92
  支付其他与筹资活动有关的现金11,062,507.095,369,429.0419,675,482.6614,694,877.89
  筹资活动现金流出小计216,612,129.6495,088,310.3589,956,151.1358,270,569.81
  筹资活动产生的现金流量净额46,336,685.3511,701,689.65206,163,280.71181,088,776.58
四、汇率变动对现金及现金等价物的影响37,083.01-350,302.24-1,679,325.05-385,166.51
五、现金及现金等价物净增加额-226,504,306.55-80,953,572.55-169,689,595.69-181,388,957.54
  加:期初现金及现金等价物余额450,945,370.42450,945,370.42620,634,966.11620,634,966.11
  期末现金及现金等价物余额224,441,063.87369,991,797.87450,945,370.42439,246,008.57
补充资料:
  净利润-244,943,112.04--432,745,046.85-
  资产减值准备207,875.8-7,745.43-
  固定资产和投资性房地产折旧3,226,338.27-6,765,409.8-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧3,226,338.27-6,765,409.8-
  无形资产摊销9,796,298.72-12,980,853.76-
  长期待摊费用摊销1,652,952.1-2,765,656.4-
  处置固定资产、无形资产和其他长期资产的损失-46,782.14-610.68-
  固定资产报废损失--2,518.59-
  公允价值变动损失-3,035,445.43--6,822,715.63-
  财务费用3,623,938.65-11,724,507.24-
  投资损失-9,959,722.35--15,022,930.99-
  递延所得税172,282.07--305,910.69-
  其中:递延所得税资产减少168,699.27--305,910.69-
    递延所得税负债增加3,582.8---
  存货的减少-3,284,193.03--14,708,285.92-
  经营性应收项目的减少-59,570,498.85--68,021,158.59-
  经营性应付项目的增加-12,958,487.75-53,987,434.08-
  其他2,295,334.38-17,503,703.51-
  现金的期末余额224,441,063.87-450,945,370.42-
  减:现金的期初余额450,945,370.42-620,634,966.11-
  现金及现金等价物的净增加额-226,504,306.55--169,689,595.69-
公告日期2026-08-292026-04-302026-04-182025-10-30
审计意见(境内)标准无保留意见
TOP↑